Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Genprex, Inc. logo — Genprex is a gene therapy company focused on developing life...

Genprex, Inc.

Genprex is a gene therapy company focused on developing life-changing technologies for patients with cancer & diabetes.

Founded 2009 United States Austin, United States 24 employees Post Ipo Equity Total: $89.40M Biopharma, Biotechnology +1

General Information

Company Name Genprex, Inc.
Founded Year 2009
Location United States Austin, United States +1
Founders / Decision Makers
Team member
Employees 24
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Post Ipo Equity
Social

Get notified when Genprex, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Genprex, Inc.

Genprex is a biopharmaceutical startup founded in 2009, dedicated to pioneering life-altering therapies for cancer and diabetes through advanced gene therapy technologies. The company's innovative approach targets the delivery of disease-fighting genes, with the aim of creating new and effective treatment options for underserved patient populations. Genprex collaborates with leading institutions and experts to advance its pipeline of gene therapy drug candidates, introducing novel approaches to patient care. Their most recent milestone includes a $6.50M Post-IPO Equity investment on 19 March 2024. With a focus on the Biopharma, Biotechnology, and Pharmaceutical industries, Genprex is positioned to make a significant impact in the field of gene therapy and life-changing therapeutic solutions.

Taxonomy: gene therapy, cancer treatment, diabetes treatment, clinical-stage company, disease-fighting genes, innovative technology, drug candidates, pipeline development, collaborative partnerships

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 19 Mar 2024
Post-IPO Equity •••••• - 19 Jul 2023
Post-IPO Equity •••••• 1
Investor
27 Feb 2023
Post-IPO Equity •••••• - 09 Feb 2021
Post-IPO Equity •••••• - 28 May 2020

View All 10 Funding Rounds

Genprex, Inc. Alternatives & Competitors

Genprex, Inc. vs
MedPacto
MedPacto Korea South

MedPacto is a genome-based drug discovery and clinical-stage biotechnology company that is pursuing...

24 employees
Genprex, Inc. vs
Vyriad
Vyriad United States

Vyriad is a clinical-stage biotech company developing targeted genetic therapies that deliver genes...

Series B
51 employees
Biotechnology
Genprex, Inc. vs
Alliance for Cancer Gene Therapy
Alliance for Cancer Gene Therapy United States

Momentous change has happened, and a cancer-free future is possible -- thanks to cell and gene thera...

10 employees
Health Care, Health and Wellness

FAQ About Genprex, Inc.

Genprex is a gene therapy company focused on developing life-changing technologies for patients with cancer & diabetes.
Genprex, Inc. was founded in 2009.
Genprex, Inc. is headquartered in Austin, United States.
Genprex, Inc. operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.
Genprex, Inc. has approximately 24 employees.
Genprex, Inc. has completed 10 funding rounds, raising a total of $89.40M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Genprex, Inc. include MedPacto, Vyriad, Alliance for Cancer Gene Therapy, Lineage Cell Therapeutics, Genelux. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genprex, Inc. and MedPacto are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Genprex, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy